Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

NCT02079896 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
End Stage Renal Disease

Interventions

DRUG: Lexaptepid pegol (NOX-H94)
DRUG: Placebo

Sponsor

TME Pharma AG